Effects of STX209 (Arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: A randomized, controlled, phase 2 trial

Elizabeth M. Berry-Kravis, David R Hessl, Barbara Rathmell, Peter Zarevics, Maryann Cherubini, Karen Walton-Bowen, Yi Mu, Danh V. Nguyen, Joseph Gonzalez-Heydrich, Paul P. Wang, Randall L. Carpenter, Mark F. Bear, Randi J Hagerman

Research output: Contribution to journal › Article › peer-review

217 Scopus citations

Fingerprint Dive into the research topics of 'Effects of STX209 (Arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: A randomized, controlled, phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences